ICON plc Given New $52.00 Price Target at Robert W. Baird (ICLR)
Equities researchers at Robert W. Baird lifted their target price on shares of ICON plc (NASDAQ:ICLR) from $47.00 to $52.00 in a research report issued on Thursday, Analyst Ratings Network reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s target price points to a potential upside of 19.38% from the company’s current price.
Separately, analysts at UBS AG initiated coverage on shares of ICON plc in a research note to investors on Tuesday, September 17th. They set a “buy” rating and a $50.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $44.43.
Shares of ICON plc (NASDAQ:ICLR) traded down 0.50% on Thursday, hitting $43.56. The stock had a trading volume of 231,331 shares. ICON plc has a 52 week low of $22.43 and a 52 week high of $40.98. The stock’s 50-day moving average is $38. and its 200-day moving average is $34.76. The company has a market cap of $2.651 billion and a P/E ratio of 33.39.
ICON plc (NASDAQ:ICLR) last released its earnings data on Thursday, October 24th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.04. The company had revenue of $339.80 million for the quarter, compared to the consensus estimate of $332.58 million. During the same quarter in the previous year, the company posted $0.29 earnings per share. The company’s revenue for the quarter was up 19.0% on a year-over-year basis. On average, analysts predict that ICON plc will post $1.67 earnings per share for the current fiscal year.
ICON public limited company (NASDAQ:ICLR) is a contract research organization (CRO), providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.